Making AI work where it matters, with Rob DiCicco

In a new pharmaphorum podcast, web editor Nicole Raleigh was joined by Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, for a conversation on the barriers and the breakthroughs in making AI work in drug development and clinical trials. DiCicco discusses why AI adoption in clinical trials is so different from preclinical research and development, as well as how synthetic control arms and in silico modelling reshape trial design, and he touches upon the need for making AI solutions meet not just regulatory and scientific standards, but ethical standards, also. You can listen to episode 250 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.